Neuregulin-1 and schizophrenia in the genome-wide association study era
Md Shaki Mostaid, David Lloyd, Benny Liberg, Suresh Sundram, Avril Pereira, Christos Pantelis, Tim Karl, Cynthia Shannon Weickert, Ian P Everall, Chad A Bousman
Neuroscience & Biobehavioral Reviews | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2016
Awarded by NHMRC
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by National Health and Medical Research Council (Australia)
Awarded by Brain and Behavior Research Foundation (NARSAD) Young Investigator Award
MM was supported by a Cooperative Research Centre for Mental Health Top-up Scholarship. SS and AP were supported by One-in-Five Association Incorporated. CP was supported by an NHMRC Senior Principal Research Fellowship (#628386), and a Brain and Behavior Research Foundation (NARSAD) Distinguished Investigator Award. TIC is supported by a Career Development Fellowship (Level 2: #1045643) and a project grant (#1102012) from the National Health and Medical Research Council (NHMRC), as well as the Rebecca L. Cooper Medical Research Foundation Ltd. CSW is supported by Schizophrenia Research Institute (utilizing infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. CSW is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship (#1021970). CAB was supported by a University of Melbourne Ronald Phillip Griffith Fellowship and Brain and Behavior Research Foundation (NARSAD) Young Investigator Award (#20526). None of the Funding Sources played any role in interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.